A Brand New Network
for ADC Discovery Success

Built by the ADC Discovery community for the ADC Discovery community

The Accelerated ADC Discovery Searchlight network is a vital year-round experience-sharing and problem-solving network to help drug developers make better ADC discovery decisions through robust scientific exchange that accelerate the next generation of ADCs to the clinic and beyond.

It’s purpose is to assemble a unique collective of drug developers that work together to overcome their most critical shared barriers to successful ADC discovery.

Members will evaluate ADC characterisation platforms and re-think target identification and validation techniques, access new thinking, new technologies and new ways of doing things.

And robust peer-to-peer dialogue around the developability of ADCs will allow members to make better informed discovery decisions that improve the likelihood of clinical success.

Save time and

Leverage a diversity
of opinion

Make valuable

Avoid costly discovery dead-ends and improve the likelihood of clinical success, with timely insights and access to unpublished information.

Deepen ADC scientific understanding by applying best-in-class science and learning about what hasn’t worked as well as what has.

Plug into a unique collective of drug developers working together to overcome their most critical shared barriers to successful ADC discovery.

Members are ADC discovery pioneers from drug developers including:

Searchlight - LEAP HR - Exec Summary lock up (3)

Membership brochure

For more information on what is included as part of the Accelerated ADC Discovery: Searchlight membership please download our membership brochure.

What will you learn? 

  • What's included in membership 
  • The member experiences 
  • The benefits of membership 
  • Who can you expect to be networking with? 
  • How to join the network

Our members say it best...

Kyla Driscoll, Executive Director Biologics Discovery, Loxo Oncology at Lilly

This network presents the golden opportunity to leverage the learnings from both our successes and our failures; boost our visibility and tap into where the industry is going next. 

Benjamin Fabre, Antibody-Drug Conjugates & Development Scientist Expert, Sanofi

This network is a powerful platform to create what is missing in this space – a strong global community having notable discussions, moving forward faster around the problems we all face”.

Hans-Georg Lerchen, CSO, Vincerx Pharma

The biggest take away for me would be the opportunity to innovatecollaborate and network – boosting the quality of my interactions and exchange of experience”.

To read more reviews about Accelerated ADC Discovery: Searchlight membership, visit our testimonials page. 

Who qualifies for the Accelerated ADC Discovery Searchlight network


Strategic ADC-focused discovery leaders

Motivated to share

Insight from the clinic

Member companies are represented by one internal champion who has strategic oversight of its ADC Discovery activities

Members will require a collaborative mindset, motivated by what can be shared as opposed to being defined by what can’t

Members will be curated based on the development stage (with those either in or close to reaching the clinic having priority)